BLACK DIAMOND THERAPEUTICS I shareholders Q3 2023

BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 73 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q3 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.

BLACK DIAMOND THERAPEUTICS I shareholders Q3 2023
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 634,191$1,820,1282.14%
NEA Management Company, LLC 4,448,757$12,767,9330.99%
CHI Advisors LLC 720,000$2,066,4000.82%
Bellevue Group AG 8,135,839$23,349,8580.38%
Parkman Healthcare Partners LLC 520,587$1,494,0850.27%
Artal Group S.A. 2,046,517$5,8740.25%
RA Capital Management 3,525,754$10,118,9140.20%
Ikarian Capital, LLC 555,572$1,594,4920.19%
TANG CAPITAL MANAGEMENT LLC 400,000$1,148,0000.16%
Newtyn Management, LLC 205,000$588,3500.14%
EAM Investors, LLC 207,428$595,3180.12%
Eversept Partners, LP 337,131$967,5660.08%
Boxer Capital, LLC 506,000$1,452,2200.08%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 930,447$2,670,3830.06%
Verition Fund Management LLC 1,735,669$4,981,3700.06%
KENNEDY CAPITAL MANAGEMENT LLC 750,292$2,153,3380.05%
Quantamental Technologies LLC 13,231$37,9730.04%
HERBST GROUP, LLC 13,635$39,1320.03%
DRIEHAUS CAPITAL MANAGEMENT LLC 696,969$2,000,3010.03%
Beacon Capital Management, LLC 15,615$78,8560.02%
External links

This page lists BLACK DIAMOND THERAPEUTICS I's shareholders in Q3 2023. To view BLACK DIAMOND THERAPEUTICS I's shareholder history, click here.